Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.96 is 41% below its 5-year average of 3.31, near the low end of its 5-year range (0.76–31.41).
As of the fiscal period ended Tuesday, June 30, 2026. 15.14% above its 12-month average of 1.70.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.96.
QUICK RATIO (ACID-TEST)
1.96
QUICK RATIO (ACID-TEST) AVG TTM
1.70
QUICK RATIO (ACID-TEST) AVG 3Y
1.51
QUICK RATIO (ACID-TEST) AVG 5Y
3.31
QUICK RATIO (ACID-TEST) AVG 10Y
2.08
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+15.14%
CURRENT VS 3Y AVG
+29.73%
CURRENT VS 5Y AVG
-40.75%
CURRENT VS 10Y AVG
-5.89%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.11
median of 696 covered companies
CURRENT VS SECTOR MEDIAN
-36.98%
vs the sector median at left
Bionano Genomics, Inc.
Market Cap
$16.81M
Quick Ratio (Acid-Test)
1.96
TTM Avg
1.70
3Y Avg
1.51
5Y Avg
3.31
Market Cap
$16.58M
Quick Ratio (Acid-Test)
1.65
TTM Avg
3.34
3Y Avg
3.94
5Y Avg
7.05
Market Cap
$17.14M
Quick Ratio (Acid-Test)
4.61
TTM Avg
2.49
3Y Avg
1.75
5Y Avg
2.54
Market Cap
$17.19M
Quick Ratio (Acid-Test)
11.48
TTM Avg
10.71
3Y Avg
12.62
5Y Avg
10.43
Market Cap
$17.34M
Quick Ratio (Acid-Test)
6.03
TTM Avg
7.38
3Y Avg
5.70
5Y Avg
5.02
Market Cap
$16.08M
Quick Ratio (Acid-Test)
2.09
TTM Avg
1.13
3Y Avg
1.21
5Y Avg
2.30
Market Cap
$17.66M
Quick Ratio (Acid-Test)
0.92
TTM Avg
0.83
3Y Avg
1.35
5Y Avg
1.29
Market Cap
$15.83M
Quick Ratio (Acid-Test)
1.11
TTM Avg
2.09
3Y Avg
1.19
5Y Avg
1.02
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | $16.81M | 1.96 | 1.70 | 1.51 | 3.31 |
| PAVmed Inc. (PAVM)vs › | $16.92M | 1.19 | 0.11 | 0.43 | 2.24 |
| Dyadic International, Inc. (DYAI)vs › | $16.58M | 1.65 | 3.34 | 3.94 | 7.05 |
| Palatin Technologies, Inc. (PTN)vs › | $17.14M | 4.61 | 2.49 | 1.75 | 2.54 |
| Lipocine Inc. (LPCN)vs › | $17.19M | 11.48 | 10.71 | 12.62 | 10.43 |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.34M | 6.03 | 7.38 | 5.70 | 5.02 |
| BioCardia, Inc. (BCDA)vs › | $16.08M | 2.09 | 1.13 | 1.21 | 2.30 |
| Cosmos Health Inc. (COSM)vs › | $17.66M | 0.92 | 0.83 | 1.35 | 1.29 |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.83M | 1.11 | 2.09 | 1.19 | 1.02 |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.58M | 1.24 | 4.22 | 12.60 | 18.98 |
Quick Ratio
1.96
Excludes inventory
Current Ratio
2.48
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.96 |
| 2026-03-31 | 1.59 |
| 2025-12-31 | 1.74 |
| 2025-09-30 | 1.82 |
| 2025-06-30 | 1.41 |
| 2025-03-31 | 1.34 |
| 2024-12-31 | 0.76 |
| 2024-09-30 | 0.99 |
| 2024-06-30 | 1.11 |
| 2024-03-31 | 1.13 |
| 2023-12-31 | 1.17 |
| 2023-09-30 | 1.94 |
| 2023-06-30 | 2.69 |
| 2023-03-31 | 2.87 |
| 2022-12-31 | 3.55 |
| 2022-09-30 | 5.77 |
| 2022-06-30 | 7.01 |
| 2022-03-31 | 12.12 |
| 2021-12-31 | 11.89 |
| 2021-09-30 | 18.81 |
| 2021-06-30 | 31.41 |
| 2021-03-31 | 51.22 |
| 2020-12-31 | 4.86 |
| 2020-09-30 | 0.99 |
| 2020-06-30 | 1.10 |
| 2020-03-31 | 0.58 |
| 2019-12-31 | 0.94 |
| 2019-09-30 | 2.05 |
| 2019-06-30 | 2.77 |
| 2019-03-31 | 5.65 |
| 2018-12-31 | 4.85 |
| 2018-09-30 | 4.72 |
| 2018-06-30 | 0.61 |
| 2018-03-31 | 0.44 |
| 2017-12-31 | 0.33 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
